-
Most Recent
Search Results
240 results for cmo
Why Cara Therapeutics Inc (CARA) Stock Is Plunging Today
Cara Therapeutics (CARA) stock was hit hard on Friday following poor results in its Phase 2b trial of osteoarthritis oral drug CR845.
Chipotle Rewards: How to Win a Chance of $1 to $500 From Venmo
Chipotle Rewards is finally here and the loyalty program includes a special offer that may get users anywhere from $1 to $500 on Venmo.
Novartis AG (ADR) Stock Drops on Q1 Earnings Miss
Novartis (NVS) stock took a hit on Thursday following the release of its earnings report for the first quarter of the year.
ARTL Stock Alert: The Big Reason Biopharma Artelo Biosciences Is Rocketing Today
Artelo Biosciences (ARTL) stock is soaring higher on Friday after Ladenburg analyst Michael Higgins initiated coverage of the company.
TENX Stock: 8 Things to Know About Tenax Therapeutics and PH Precision Med as Shares Rocket
Tenax Therapeutics (TENX) stock is flying high on Tuesday after announcing it has acquired biotech company PH Precision Med.
Boeing 737 News: BA Stock Hit By More Bad News
More bad Boeing 737 news has BA stock down on Monday with the FAA requiring it to fix faulty parts found in its aircraft.
Chick-fil-A Delivery Rolls Out Nationwide
Chick-fil-A delivery is a thing now and it means customers never have to leave home again, so long as they live close to a store.
Marijuana Stocks News: Tilray Stock Soars on Liquor Deal
Tilray (TLRY) is leading the marijuana stock news mill on Monday with a new liquor deal with Nova Scotia Liquor Corporation.
Dunkin’ Donuts Name Change Coming Next Year
Dunkin Brands (DNKN) will be going forward with a Dunkin’ Donuts name change next year to simplify its brand and draw in more customers.
Arvinas News Alert: Why ARVN Stock Is Skyrocketing Today
Arvinas (ARVN) news for Monday includes positive interim results from clinical trials sending ARVN stock soaring to new highs.
JAGX Stock: Why Jaguar Health Is Climbing Higher Today
Investors in JAGX stock are having a solid week, after the company made a few key announcements that have taken this stock higher.
Netflix, Inc. Won’t Languish Long If the Bulls Have Their Way (NFLX)
The market may worry about cost concerns and troubles going global, but investor sentiment in Netflix (NFLX) is too strong to be broken.
Eyenovia News: Why EYEN Stock Is Skyrocketing 33% Today
Eyenovia (EYEN) is in the news Tuesday after an exclusive deal with Arctic Vision for two of its treatments sent EYEN stock soaring higher.
Biogen Inc Stock Shoots Higher on Alzheimer’s Drug Trial
Biogen (BIIB) stock was soaring today on positive results from a recent Alzheimer’s drug trial conducted along with Eisai.
MRNA Stock: 10 Things to Know About Moderna as It Gets Ready to Join the S&P 500
Moderna (MRNA) stock is on the rise Friday as the company prepares to join the S&P 500 next week replacing Alexion Pharmaceuticals (ALXN).
Why Is Longeveron (LGVN) Stock on the Move Today?
Longeveron (LGVN) stock is on the move Wednesday after the FDA granted its fast-track designation for heart treatment Lomecel-B.
CRWD Stock Alert: What to Know About CrowdStrike’s New President
CrowdStrike (CRWD) stock is in the news Wednesday as the cybersecurity company announced Michael Sentonas as its new president.
What to Expect for Energy, REITs and Finance Investments
As the end of the year approaches, investors will want to stay on top of the latest guidance in the energy, real estate and finance…
Are Amazon, Apple, Meta and Microsoft “Buys” After Earnings?
In today’s Market 360, let’s break down what these four tech giants just reported and what it all means for your portfolio…
Vertex Pharmaceuticals News: Why VRTX Stock Is Getting Slammed 20% Today
Vertex Pharmaceuticals (VRTX) news for Thursday concerning bad results from one of its clinical trials is sending VRTX stock down.
RUBY Stock Alert: The Promising Cancer Drug News That Has Rubius Therapeutics Rocketing Today
Rubius Therapeutics (RUBY) stock was flying high on Monday after announcing early results from a clinical trial of its new cancer treatment.
RIVN Stock Analysis: The Bull and Bear Case for Betting on Rivian
According to this RIVN stock analysis, Rivian and RIVN stock could be worth buying as a speculative bet here.
Will ‘Sell in May and Go Away’ Take Hold in 2013 After All?
S&P 500 charts from the past decade illustrate why we shouldn’t start panicking about the recent market turbulence.
3 Small-Cap Dividend Stocks With Big Yields
Big, regular income checks plus a chance for share appreciation? Sounds like a winning combination to me.
6 – 10 of 240 results
